Uterine Cancer Tumor Molecular Profiling
Learn More About Tumor Molecular Profiling for Uterine Cancer: Chat with Us | Email Us
Video: Molecular Testing
Dr. Ritwick Panicker, a medical oncologist and hematologist at Cancer Treatment Centers of America, explains molecular testing and how it enables doctors to personalize cancer treatment.Molecular Testing
Dr. Ritwick Panicker, a medical oncologist and hematologist at Cancer Treatment Centers of America, explains molecular testing and how it enables doctors to personalize cancer treatment.
Our goal at Cancer Treatment Centers of America (CTCA) is to develop a uterine cancer treatment plan suited to your needs. We perform tumor molecular profiling to identify chemotherapy drugs that have clinical benefits and may be more likely to work for you.
By choosing more effective drugs, we can avoid unnecessary toxicity to you and target cancer cells as aggressively as possible from the start.
Our oncologists use this type of molecular profiling to:
- Identify the unique the molecular “blueprint” of each patient’s uterine cancer tumor.
- Choose cancer treatments that are more likely to be effective and rule out those that are unlikely to be effective, on an individual patient basis – minimizing trial and error.
- Discover potentially beneficial treatment options that may not have been considered in an initial treatment plan.
If you have surgery or a biopsy, we’ll collect a sample of your uterine cancer tumor. Then, we’ll use tumor molecular profiling to test for the presence of a variety of enzymes and genetic mutations to identify which therapies are likely to be most effective.
Next Topic: Hormone Therapy for Uterine Cancer
